Which hedge funds own ZBH? ZIMMER BIOMET HOLDINGS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
12 of the hedge funds tracked by WhaleCreep disclosed a position in ZBH (ZIMMER BIOMET HOLDINGS INC) in their Q2 2026 13F filings, worth $618.0m in total. The largest holder by portfolio weight is Moore Capital Management at 0.4% of its book. 5 managers opened a new position this quarter: Moore Capital Management, Point72 Asset Management LP, Tudor Investment, Millennium Management. 2 exited: First Manhattan, Renaissance Technologies LLC.
12tracked managers holding
5opened this quarter
2exited this quarter
Which hedge funds hold ZBH? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Moore Capital Management | Q2 2026 | 0.4% | $17.1m | 198,642 | – | new |
| Woodline Partners | Q2 2026 | 0.3% | $81.1m | 942,300 | 1186% | added |
| Holocene Advisors | Q2 2026 | 0.2% | $101.4m | 1,177,461 | 98% | added |
| Citadel Advisors | Q2 2026 | 0.2% | $299.4m | 3,477,472 | 152% | added |
| Point72 Asset Management LP | Q2 2026 | 0.1% | $75.7m | 879,851 | – | new |
| Tudor Investment | Q2 2026 | 0.0% | $6.2m | 71,996 | – | new |
| Millennium Management | Q2 2026 | 0.0% | $19.1m | 222,065 | – | new |
| Bridgewater Associates | Q2 2026 | 0.0% | $3.1m | 36,150 | 6% | added |
| Marshall Wace | Q2 2026 | 0.0% | $12.4m | 144,500 | – | new |
| Suvretta Capital Management | Q2 2026 | 0.0% | $280.7k | 3,260 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $2.1m | 24,120 | 164% | added |
| Ancora Advisors | Q2 2026 | 0.0% | $29.4k | 342 | -63% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| First Manhattan | 0.0% | $211.4k |
| Renaissance Technologies LLC | 0.1% | $5.5m |
How has hedge fund ownership of ZBH changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 12 | $618.0m |
| Q1 2026 | 9 | $194.9m |
| Q4 2025 | 8 | $44.4m |
| Q3 2025 | 8 | $65.4m |
| Q2 2025 | 6 | $58.1m |
| Q1 2025 | 7 | $73.1m |
| Q4 2024 | 7 | $132.5m |
| Q3 2024 | 8 | $157.0m |
| Q2 2024 | 8 | $183.0m |
| Q1 2024 | 7 | $201.1m |
| Q4 2023 | 6 | $124.0m |
| Q3 2023 | 8 | $336.7m |
| Q2 2023 | 7 | $407.3m |
| Q1 2023 | 8 | $299.4m |
| Q4 2022 | 7 | $301.7m |
| Q3 2022 | 6 | $224.0m |
Counts every tracked manager that disclosed ZBH in that quarter's filing, including managers that have since stopped filing.